ACE inhibitors induce angioedema in 0.1–0.7% of recipients, and although the rate is relatively low, the wide use of these drugs, with more than 40 million patients receiving them on a daily basis worldwide, makes them the most common cause of drug-induced angioedema [7,8,9,10]. The gene discussed is ACE; the disease is angioedema.